Plasma proteomics improves thrombosis prediction in patients with cancer and identifies targetable IL-17–driven endothelial activation | Science Translational Medicine
Plasma proteomics improves thrombosis prediction in cancer and uncovers a targetable CD200R1/IL-17–driven endothelial activation pathway in mice.
